梅花生物
(600873)
| 流通市值：222.94亿 | | | 总市值：222.94亿 |
| 流通股本：28.04亿 | | | 总股本：28.04亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,877,767,910.42 | 2,641,777,808.24 | 4,288,171,778.59 | 4,543,402,233.92 |
| 交易性金融资产 | 1,977,052,675.2 | 1,049,911,128.18 | 1,140,377,416.7 | 1,975,859,174.33 |
| 衍生金融资产 | 2,181,653.58 | 270,800 | 2,061,300 | 1,961,200 |
| 应收票据及应收账款 | 685,879,789.52 | 676,585,265.61 | 684,913,644.65 | 681,436,041.5 |
| 其中：应收票据 | 36,626,560.85 | 79,132,785.22 | 107,542,558.59 | 111,035,787.13 |
| 应收账款 | 649,253,228.67 | 597,452,480.39 | 577,371,086.06 | 570,400,254.37 |
| 应收款项融资 | 32,134,493.66 | 114,724,414.09 | 17,978,363 | 53,509,657.67 |
| 预付款项 | 142,397,572.45 | 206,232,132.5 | 171,884,582.59 | 96,190,131.99 |
| 其他应收款合计 | 62,537,139.77 | 28,999,693.51 | 70,477,156.58 | 16,164,594.32 |
| 其中:应收利息 | 2,362,500 | 1,989,512.07 | 1,575,000 | 1,181,250 |
| 应收股利 | - | 1,395,866.49 | 1,395,866.49 | 1,395,866.49 |
| 存货 | 3,996,122,827.78 | 4,597,631,588.86 | 3,021,627,701.05 | 2,176,152,704.15 |
| 一年内到期的非流动资产 | 606,208,384.81 | 182,291,406.52 | 75,575,625.48 | 32,618,430.7 |
| 其他流动资产 | 376,523,005.53 | 320,808,927.69 | 214,731,083.57 | 285,015,832.76 |
| 流动资产合计 | 10,758,805,452.72 | 9,819,233,165.2 | 9,687,798,652.21 | 9,862,310,001.34 |
| 非流动资产: | | | | |
| 债权投资 | 10,500,000 | 10,500,000 | 10,500,000 | 10,500,000 |
| 长期应收款 | 224,781.42 | 228,934.44 | 233,244.15 | 472,467.45 |
| 长期股权投资 | 2,635,435.8 | 4,096,791.78 | 4,757,925.21 | 4,840,506.23 |
| 其他权益工具投资 | 229,089,650 | 287,235,125 | 301,966,810 | 350,551,760 |
| 其他非流动金融资产 | 346,396,575.38 | 283,595,630.49 | 282,005,000 | 300,710,000 |
| 固定资产 | 12,127,838,360.07 | 12,413,139,089.43 | 12,768,478,381.36 | 11,325,954,551.42 |
| 在建工程 | 1,285,969,127.79 | 585,392,295.97 | 343,559,937.21 | 1,604,241,101.08 |
| 使用权资产 | 2,330,281.28 | 3,165,323.87 | 4,007,321.13 | 6,052,460.79 |
| 无形资产 | 1,431,155,275.44 | 1,554,622,267.51 | 1,557,280,758.01 | 1,555,405,260.79 |
| 商誉 | 11,788,911.79 | 11,788,911.79 | 11,788,911.79 | 11,788,911.79 |
| 长期待摊费用 | 150,580,694.96 | 131,608,005.88 | 133,781,048.89 | 141,730,644.21 |
| 递延所得税资产 | 144,936,109.43 | 127,889,375.89 | 126,369,580.18 | 120,520,078.65 |
| 其他非流动资产 | 283,174,780.22 | 736,174,420.86 | 683,449,155.24 | 696,262,159.35 |
| 非流动资产合计 | 16,026,619,983.58 | 16,149,436,172.91 | 16,228,178,073.17 | 16,129,029,901.76 |
| 资产总计 | 26,785,425,436.3 | 25,968,669,338.11 | 25,915,976,725.38 | 25,991,339,903.1 |
| 流动负债: | | | | |
| 短期借款 | 1,831,796,712.9 | 1,836,557,738.45 | 1,800,136,227.43 | 1,834,996,073.76 |
| 衍生金融负债 | 42,227.58 | 1,397,055.38 | - | - |
| 应付票据及应付账款 | 4,078,627,753.51 | 3,301,240,263.1 | 3,512,238,291.61 | 3,383,550,154.65 |
| 其中：应付票据 | 2,259,312,216.46 | 1,837,586,180.32 | 1,777,053,969.91 | 1,712,756,037.72 |
| 应付账款 | 1,819,315,537.05 | 1,463,654,082.78 | 1,735,184,321.7 | 1,670,794,116.93 |
| 合同负债 | 656,266,656.92 | 888,573,512.63 | 746,778,983.64 | 949,096,044 |
| 应付职工薪酬 | 290,464,932.1 | 353,959,730.62 | 392,494,934.53 | 416,796,293.13 |
| 应交税费 | 212,820,799.37 | 207,407,622.64 | 194,688,876.58 | 300,652,332.96 |
| 其他应付款合计 | 1,437,537,640.7 | 274,629,079.38 | 256,349,893.68 | 261,321,008.74 |
| 应付股利 | 1,200,340,002.04 | 405,000 | 405,000 | 405,000 |
| 一年内到期的非流动负债 | 234,060,518.78 | 133,621,827.17 | 281,057,349.33 | 373,437,753.7 |
| 其他流动负债 | 46,050,129.71 | 84,259,349.64 | 79,369,933.52 | 126,632,613.62 |
| 流动负债合计 | 8,787,667,371.57 | 7,081,646,179.01 | 7,263,114,490.32 | 7,646,482,274.56 |
| 非流动负债: | | | | |
| 长期借款 | 1,957,357,123.82 | 2,080,063,223.85 | 1,918,679,223.83 | 1,821,343,675.44 |
| 租赁负债 | 482,287.52 | 741,108.63 | 1,012,966.64 | 1,854,550.76 |
| 长期应付款 | 23,457,549.63 | 24,382,278.26 | 10,500,000 | 10,500,000.2 |
| 长期应付职工薪酬 | - | 7,356,660.54 | 7,474,640.65 | 6,514,442.65 |
| 预计负债 | - | - | - | 3,829,175.05 |
| 递延收益 | 345,546,673.63 | 357,269,446.28 | 367,624,988.38 | 364,444,376.75 |
| 递延所得税负债 | - | - | - | 20,536,638.24 |
| 非流动负债合计 | 2,326,843,634.6 | 2,469,812,717.56 | 2,305,291,819.5 | 2,229,022,859.09 |
| 负债合计 | 11,114,511,006.17 | 9,551,458,896.57 | 9,568,406,309.82 | 9,875,505,133.65 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,804,241,650 | 2,804,241,650 | 2,804,241,650 | 2,804,241,650 |
| 资本公积 | 33,749,867.59 | 33,749,867.59 | 33,749,867.59 | 33,749,867.59 |
| 减:库存股 | 39,999,676.57 | - | - | - |
| 其他综合收益 | -258,986,565.2 | -208,692,530.06 | -159,220,172.21 | -135,107,124.62 |
| 专项储备 | 6,174,999.62 | 6,184,039.44 | 4,992,619.68 | 4,931,483.03 |
| 盈余公积 | 1,379,865,682.01 | 1,379,865,682.01 | 1,379,865,682.01 | 1,212,273,753.22 |
| 未分配利润 | 11,745,868,472.68 | 12,401,861,732.56 | 12,283,940,768.49 | 12,195,745,140.23 |
| 归属于母公司股东权益合计 | 15,670,914,430.13 | 16,417,210,441.54 | 16,347,570,415.56 | 16,115,834,769.45 |
| 股东权益合计 | 15,670,914,430.13 | 16,417,210,441.54 | 16,347,570,415.56 | 16,115,834,769.45 |
| 负债和股东权益合计 | 26,785,425,436.3 | 25,968,669,338.11 | 25,915,976,725.38 | 25,991,339,903.1 |
| 公告日期 | 2026-08-15 | 2026-04-22 | 2026-04-22 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |